Skip to main content

Headlines

Lilly's EloraTZP Delivers Weight Loss Results In Phase 2b Trial
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
posted:
by: CNBC Business
#channels:: #All, #News, #Business, #CNBCBusiness, #CNBC, #Stocks, #Markets
Jade Biosciences Advances JADE301 Toward Phase 1 Trial In Dermatomyositis
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Silexion Doses First Patient In Phase 2/3 SIL204 Trial For Pancreatic Cancer
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Satellos Completes Enrollment In Phase 2 Forazapadin Trial For DMD
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Takeda Says Zasocitinib Tops Deucravacitinib With Superior Skin Clearance In Phase 3 Trial
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Takeda's Zasocitinib Shows Superior Skin Clearance In Phase 3 Psoriasis Trial
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Lilly's Retatrutide Delivered Significant Weight Loss, A1C Reduction In Phase 3 Trial
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
UniQure Stock Falls 37% After Huntington's Disease Trial Update
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Moleculin Completes Part A Enrollment In Phase 2/3 MIRACLE Trial For Relapsed AML
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Pokemon Fan Charged With $55 Million Crypto Hack Goes on Trial
posted:
by: Bloomberg BusinessWeek
#channels:: #All, #Business, #Technology, #Bloomberg, #BloombergBusinessWeek, #Stocks
Medicus Pharma Files Phase 2b/3 Trial Design For Teverelix
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Ascletis' ASC50 Shows 48.9% PASI Reduction In Phase 1 Psoriasis Trial
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Tiziana Begins Phase 2a BANYAN Trial Of Intranasal Foralumab In ALS Patients
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
4D Molecular Enrolls First Patient In Phase 3 4SIGHT Trial, Reports Durable 2-Year SPECTRA Data
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks